This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: The Translational Genomics Research Institute, Unversität Zürich. Active years: 2011-2013.
Company Filing History:
2 out of 124 
1 out of 276 
Years Active: 2011-2013
Title: Andreas Papassotiropoulos: Innovator in Alzheimer's Disease Research
Introduction
Andreas Papassotiropoulos is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of genetics, particularly in relation to Alzheimer's disease. With a total of 2 patents, his work focuses on understanding the genetic markers associated with late-onset Alzheimer's disease and human memory performance.
Latest Patents
Papassotiropoulos's latest patents include groundbreaking methods for diagnosing Alzheimer's disease. One patent details genetic markers and methods for screening late-onset Alzheimer's disease (LOAD). This disclosure encompasses a whole-genome association analysis of single nucleotide polymorphisms (SNPs), identifying novel haplotypes within the GRB2-associated binding protein 2 (GAB2) gene. These haplotypes are crucial as they modify LOAD risk in combination with APOE alleles. Additionally, his work includes therapeutic methods aimed at decreasing the deterioration of cells associated with LOAD. Another patent focuses on DNA sequences linked to human memory performance, providing methods for screening diseases affecting memory and identifying treatment agents.
Career Highlights
Throughout his career, Papassotiropoulos has worked with esteemed institutions such as the Translational Genomics Research Institute and Universität Zürich. His research has significantly advanced the understanding of genetic factors influencing Alzheimer's disease and memory performance.
Collaborations
He has collaborated with notable colleagues, including Dietrich A. Stephan and Dominique J-f De Quervain, contributing to the advancement of research in his field.
Conclusion
Andreas Papassotiropoulos is a key figure in Alzheimer's disease research, with innovative patents that enhance the understanding of genetic influences on memory and disease. His contributions continue to pave the way for future advancements in the field.